1261O Neoadjuvant nivolumab (N) + ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial
Annals of Oncology(2023)
关键词
1261o neoadjuvant nivolumab,chemotherapy,ipilimumab,phase iii checkmate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要